• TARX share price: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • TARX stock price change: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • TARX market open/close: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

Key terms

About TARX

Tarsier Pharma Ltd. is a biopharmaceutical company which engages in the development and commercialization of pharmaceutical therapies to address unmet need in ocular diseases with underlying inflammatory pathologies. The company was founded by Daphne Haim-Langford in February 2016 and is headquartered in Zichron Yaacov, Israel.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

  • TARX market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Smart score

Latest TARX news

Jul 13, 2026 12:40pm ET Opening Day: SK Hynix makes loud U.S. arrival in otherwise quiet week for IPOs by TipRanks Jul 06, 2026 10:30am ET Opening Day: Bending Spoons tops pricing range in market debut by TipRanks Jun 30, 2026 9:40am ET Opening Day: Sinda, Doncasters, DSC Holdings begin trading by TipRanks Jun 23, 2026 3:16pm ET Tarsier Pharma 5M share IPO price range $8.00-$10.00 by TipRanks Jun 23, 2026 10:45am ET Tarsier Pharma 5M share IPO price range $8.00-$10.00 by TipRanks Jun 15, 2026 11:07am ET Opening Day: SpaceX jumps on first day of trading, surges past $2T by TipRanks Jun 08, 2026 11:40am ET Opening Day: Quantinuum among strong IPO debuts by TipRanks

No recent press releases are available for TARX

TARX Financials

1-year income & revenue

  • TARX total revenue: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • TARX net income: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • TARX earnings per share: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

Key terms

TARX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

TARX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range
  • How competitors are chosen

    TARX's competitors are included in the Health Technology sector and Biotechnology group

  • TARX market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Latest investing news